SCHEMBL2199524

SCHEMBL2199524

CS(=O)(=O)c1nccc(-c2ccc3cccc-3o2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.38
RAB9A P51151 3/20 0.38
TP53 P04637 2/20 0.38
HPGD P15428 2/20 0.38
STAT3 P40763 2/20 0.38
HTT P42858 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
HSD17B10 Q99714 2/20 0.38
NPC1 O15118 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
JAK2 O60674 1/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TLR8 Q9NR97 1/20 0.38
EGFR P00533 1/20 0.38
CYP3A4 P08684 1/20 0.38
BRAF P15056 1/20 0.38
JAK3 P52333 1/20 0.38
MAPK10 P53779 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21621272 0.78 ALDH1A1 (0.58) PTGS2RAB9ATP53HPGDSTAT3
SCHEMBL30107948 0.78 ALDH1A1 (0.58) PTGS2RAB9ATP53HPGDSTAT3
SCHEMBL30122726 0.77 SDHB (0.47) RAB9ATP53HPGDSTAT3HTT
SCHEMBL4447801 0.76 BPTF (0.54) PTGS2RAB9ATP53HPGDSTAT3
SCHEMBL2202979 0.74 POLB (0.42) HPGDHTTNPSR1HSD17B10KDM4E
SCHEMBL17561035 0.72 DYRK1A (0.49) RAB9ANPC1EGFRCYP3A4BRAF
SCHEMBL2199521 0.72 GRM4 (0.59) RAB9ATP53HPGDHSD17B10NPC1
SCHEMBL3572760 0.72 HSP90AA1 (0.57) PTGS2RAB9ANPC1ALDH1A1EGFR
SCHEMBL29369021 0.71 RAB9A (0.41) PTGS2RAB9ATP53HPGDSTAT3
Hydrochloric Acid SCHEMBL2200236 0.70 NPC1 (0.38) RAB9ANPC1KDM4EJAK2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977358-B2 Pyrazol derivatives HOFFMANN-LA ROCHE INC. (US) 2011-07-12 US disclosed
EP-2182953-A2 NEW PYRAZOL DERIVATIVES F. Hoffmann-Roche AG (CH) 2010-05-12 EP disclosed
US-20090029963-A1 PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 US disclosed
WO-2009013211-A2 NEW PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029963-A1 PYRAZOL DERIVATIVES CCR1, CCR3, CCRL2 PTGS2 837/4885RAB9A 3187/4885TP53 3028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.